Munich Startup: What does your startup do? What problem do you solve?
Frank Wallrapp, CEO and Co-Founder: We are developing Tailor-made enzyme solutionsThese technologies enable the efficient conversion of industrial biomass by-products into sustainable, non-food-based sugars. This solves the problem that large quantities of valuable biomass are currently used inefficiently or not at all, while food-based raw materials are simultaneously consumed in the biotechnology and chemical industries.
Waste-based and other second-generation raw materials only have a chance to be a real game changer if sustainability and higher profits go hand in hand, as is the case here.
Munich Startup: But that's been around for a long time!
Frank Wallrapp: Standard enzymes are often non-specific and not economically optimal for the customer's specific biomass. We develop customized enzyme cocktails with a clear focus on industrial scalability and profitability. Furthermore, we offer licensing models and technology transfer for on-site production models, which further increases profitability and sustainability.
Utilizing the potential of biomass
Munich Startup: What is your founding story?
Frank Wallrapp: We both come from industrial enzyme development and worked hand in hand for many years at our previous employer. We saw how much potential biomass holds, but that this potential is often not realized economically. This led to the vision of finally making 2G bioconversion profitable and suitable for industrial applications – faster, more agile, and more customer-specific than is often possible at corporations.
Munich Startup: What have been your biggest challenges so far?
Frank Wallrapp: The combination of technology development, laboratory setup, and simultaneous market validation. It is particularly challenging to consider industrial realities from the outset, both technically and economically. However, this is a major focus for us.
Twogee Biotech was founded in 2024 by Frank Wallrapp and Helge Jochens founded. The two have known each other for over twelve years from their time together at the Clariant Group and bring many years of experience in industrial enzyme development.
The vision: A global player in biomass utilization
Munich Startup: Where would you like to be in one year, where in five years?
Frank Wallrapp: In one year: several ongoing industrial projects with a clear scaling perspective.
In five years: an established technology partner for profitable 2G biomass utilization in Europe and beyond.
Munich Startup: How have you experienced Munich as a startup location so far?
Frank Wallrapp: Extremely supportive. Munich and the surrounding area have an extremely strong network, a good investor landscape, excellent research, and short paths between industry and innovation.
Munich Startup: Hidden champion or shooting star?
Frank Wallrapp: A long-term hidden champion, with the pace of a shooting star.
